---
title: "Zoledronic Acid - Postmenopausal Osteoporosis"
sidebar: mydoc_sidebar
permalink: db00399-mesh-d015663-1.html
toc: false 
---


Path ID: `DB00399_MESH_D015663_1`
{% include image.html url="images/db00399-mesh-d015663-1.png" file="db00399-mesh-d015663-1.png" alt="db00399-mesh-d015663-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C088658">MESH:C088658 </a> | zoledronic acid | Drug |
| <a href="https://identifiers.org/UniProt:P14324">UniProt:P14324 </a> | Farnesyl pyrophosphate synthase | Protein |
| <a href="https://identifiers.org/UniProt:O95749">UniProt:O95749 </a> | Geranylgeranyl pyrophosphate synthase | Protein |
| <a href="https://identifiers.org/CHEBI:52255">CHEBI:52255 </a> | hydroxylapatite | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0008299">GO:0008299 </a> | isoprenoid biosynthetic process | BiologicalProcess |
| <a href="https://identifiers.org/GO:0001503">GO:0001503 </a> | ossification | BiologicalProcess |
| <a href="https://identifiers.org/GO:1990523">GO:1990523 </a> | bone regeneration | BiologicalProcess |
| <a href="https://identifiers.org/GO:0045453">GO:0045453 </a> | bone resorption | BiologicalProcess |
| <a href="https://identifiers.org/HP:0004349">HP:0004349 </a> | Reduced bone mineral density | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D015663">MESH:D015663 </a> | Postmenopausal osteoporosis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Zoledronic Acid | DECREASES ACTIVITY OF | Farnesyl Pyrophosphate Synthase |
| Zoledronic Acid | DECREASES ACTIVITY OF | Geranylgeranyl Pyrophosphate Synthase |
| Zoledronic Acid | MOLECULARLY INTERACTS WITH | Hydroxylapatite |
| Hydroxylapatite | POSITIVELY CORRELATED WITH | Ossification |
| Hydroxylapatite | POSITIVELY CORRELATED WITH | Bone Regeneration |
| Farnesyl Pyrophosphate Synthase | POSITIVELY CORRELATED WITH | Isoprenoid Biosynthetic Process |
| Geranylgeranyl Pyrophosphate Synthase | POSITIVELY CORRELATED WITH | Isoprenoid Biosynthetic Process |
| Isoprenoid Biosynthetic Process | POSITIVELY CORRELATED WITH | Bone Resorption |
| Bone Resorption | POSITIVELY CORRELATED WITH | Reduced Bone Mineral Density |
| Reduced Bone Mineral Density | POSITIVELY CORRELATED WITH | Postmenopausal Osteoporosis |
| Ossification | NEGATIVELY CORRELATED WITH | Postmenopausal Osteoporosis |
| Bone Regeneration | NEGATIVELY CORRELATED WITH | Postmenopausal Osteoporosis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00399](https://go.drugbank.com/drugs/DB00399)
  - [https://en.wikipedia.org/wiki/Zoledronic_acid](https://en.wikipedia.org/wiki/Zoledronic_acid)
  - [https://journals.sagepub.com/doi/10.4137/BTRI.S36138](https://journals.sagepub.com/doi/10.4137/BTRI.S36138)
